Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Plos One|January 7, 2016
Efficacy and Safety of Fingolimod in an Unselected Patient PopulationMaria Rasenack, Jonathan Rychen, Michaela Andelova, et al.Neurorehabilitation and Neural Repair|March 15, 2023
Cerebrospinal Fluid Pressure Dynamics as a Bedside Test in Traumatic Spinal Cord Injury to Assess Surgical Spinal Cord Decompression: Safety, Feasibility, and Proof-of-ConceptNajmeh Kheram, Andrea Boraschi, Nikolai Pfender, et al.Journal of Neurology|November 13, 2015
The modified ultrasound pattern sum score mUPSS as additional diagnostic tool for genetically distinct hereditary neuropathiesAlexander Grimm, Maria Rasenack, Ioanna M Athanasopoulou, et al.Neurology(R) Neuroimmunology & Neuroinflammation|April 19, 2016
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML developmentMaria Meira, Claudia Sievers, Francine Hoffmann, et al.Neurology(R) Neuroimmunology & Neuroinflammation|September 18, 2015
Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MSMaria Zimmermann, Nicholas S R Sanderson, Maria Rasenack, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patientsTobias Derfuss, François Curtin, Claudia Guebelin, et al.Journal of Neuroimmunology|July 23, 2015
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-upTobias Derfuss, François Curtin, Claudia Guebelin, et al.Pageof 2